<?xml version="1.0" encoding="utf-8"?><rss version="2.0">
<channel>
<title>Health News : Articles : Rss : Job Opportunities much more...</title> 
<link>http://www.ehealthguide.info/</link> 
<description>Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient&#039;s, Health Care staff, Explains Patient Family Education and Rights.
Best Articles, Notes, Organizations and there activities to explore, to facilitate your patients, and providing quality and safety in the health care organizations. </description> 
<lastBuildDate>Wed Aug 2008</lastBuildDate>
<generator>eHealth Guide RSS - http://www.ehealthguide.info</generator>
<item>
<title>Synosia Starts Phase II Efficacy Trial For Rufinamide</title> 
<link>http://www.ehealthguide.info/read_new81221.html</link> 
<description>The trial is an eight-week, double-blind, placebo-controlled, exploratory study being    conducted in 20 sites in the United States. It will assess the efficacy and tolerability of rufinamide in up to 230 patients with general anxiety disorder, as measured by multiple psychometric assessment tools. Patients randomized to rufinamide will receive 250mg twice a day for one week followed by 500mg twice a day for seven weeks....</description>
<pubDate>Sat Apr 2008</pubDate>
</item>
    	
	
	
	
</channel>
</rss>